Albendazole Market By Type ( Tablets, Capsules ), By End-use ( Ascaris Infection Treatment, Pinworm Infection Treatment ), Industry Trends, Estimation & Forecast, 2017 - 2025

Check Today's Best Price

$3500 Buy Now
Albendazole Market is expected to grow with a CAGR of XX% during the forecast period of 2018 to 2025.
  • Market Overview:

    Albendazole is a WHO approved medication used for parasitic worm infestations. It is a broad spectrum medicine, which is also known by the name albendazolum. Albendazole is an orally administered drug that is recognized as an important and safe medicine required for the health system. The surging incidences of worm infestations, mainly among children and refugees is the main determinant that is boosting the sales of albendazole drug in the global market. The rural pockets of developing nations are the most prone areas exhibiting a rising graph of incidences regarding worm infestations. The scarcity of drinking water, poor hygiene conditions, and lack of proper sanitation in such areas of the world are the prime reasons for an increase in the parasitic worm infestations. In order to tackle such issues, in 2016, the Government of India started a nationwide deworming initiative. Under the deworming initiative, 27 crore children under the age of 1-19 year, covering 561 districts of India, were administered with albendazole tablets.

    The global albendazole market is experiencing hurdles in its market growth due to the side effects of the medicine such as headaches, nausea, bone marrow suppression, and liver inflammation among others. In addition, pregnant women are not advised to consume albendazole as it is recognized as a pregnancy category C and category D drug in the US and Australia, respectively. The market is fragmented in nature with the presence of several market players offering their product by different brand name in the global market.

    The report provides detailed qualitative and quantitative analysis of the global albendazole market. Market size and forecast in terms of value and volume has been provided for the period – (2017 – 2025), for the segments namely type, and end-use in each of the major regions of the world.

    Albendazole Market Segmentation

    By Type
    • Tablets
    • Capsules

    By End-use
    • Ascaris Infection Treatment
    • Pinworm Infection Treatment
    • Others

    By Geography

    • North America
    o U.S.
    o Canada
    o Mexico

    • Europe
    o U.K
    o France
    o Germany
    o Italy
    o Spain
    o Rest of Europe

    • Asia-Pacific
    o China
    o Japan
    o India
    o Korea
    o Rest of APAC

    • South America
    o Brazil
    o Rest of South America

    • Rest of the World
    o Middle East
    o Africa

    keyboard_arrow_up
  • CHAPTER 1. INTRODUCTION
    1.1. RESEARCH METHODOLOGY
    1.1.1. ERC desk research
    1.1.2. ERC data synthesis
    1.1.3. Data validation and market feedback
    1.1.4. ERC data sources

    CHAPTER 2. ALBENDAZOLE MARKET OVERVIEW
    2.1. ALBENDAZOLE MARKET INTRODUCTION
    2.2. GLOBAL ALBENDAZOLE MARKET PRODUCTION AND GROWTH RATE, 2017-2025
    2.2.1. Global albendazole Production (K UNITS) and Growth Rate (%), (2017-2025)
    2.3. GLOBAL ALBENDAZOLE MARKET CAPACITY AND GROWTH RATE, 2017-2025
    2.3.1. Global albendazole Capacity (K UNITS) and Growth Rate (%), (2017-2025)
    2.4. GLOBAL ALBENDAZOLE MARKET REVENUE AND GROWTH RATE, 2017-2025
    2.4.1. Global albendazole Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
    2.5. GLOBAL ALBENDAZOLE MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
    2.5.1. Global albendazole Consumption (K UNITS) and Growth Rate (%), (2017-2025)
    2.6. GLOBAL ALBENDAZOLE MARKET PRICE TREND, 2017-2025
    2.6.1. Global albendazole Market Price Trend (USD/ UNIT) and Growth Rate (%), (2017-2025)

    CHAPTER 3. GLOBAL ALBENDAZOLE MARKET BY TYPE, 2017-2025
    3.1. TABLETS
    3.2. CAPSULES
    3.3. GLOBAL ALBENDAZOLE MARKET REVENUE BY TYPE, 2017-2025
    3.3.1. Global albendazole Market Revenue (Million USD) and Share (%) By Type, 2017-2025
    3.3.2. Tablets Market Revenue and Growth Rate, 2017-2025
    3.3.3. Capsules Market Revenue and Growth Rate, 2017-2025
    3.4. GLOBAL ALBENDAZOLE MARKET PRODUCTION BY TYPE, 2017-2025
    3.4.1. Global albendazole Market Production (K UNITS) and Share (%) By Type, 2017-2025
    3.4.2. Tablets Market Production and Growth Rate, 2017-2025
    3.4.3. Capsules Market Production and Growth Rate, 2017-2025

    CHAPTER 4. GLOBAL ALBENDAZOLE MARKET BY END-USE, 2017-2025
    4.1. PINWORM INFECTION TREATMENT
    4.2. ASCARIS INFECTION TREATMENT
    4.3. OTHERS
    4.4. GLOBAL ALBENDAZOLE MARKET REVENUE BY END-USE, 2017-2025
    4.4.1. Global albendazole Market Revenue (Million USD) and Share (%) By End-use, 2017-2025
    4.4.2. Pinworm Infection Treatment Market Revenue and Growth Rate, 2017-2025
    4.4.3. Ascaris Infection Treatment Market Revenue and Growth Rate, 2017-2025
    4.4.4. Others Market Revenue and Growth Rate, 2017-2025
    4.5. GLOBAL ALBENDAZOLE MARKET CONSUMPTION BY END-USE, 2017-2025
    4.5.1. Global albendazole Market Consumption (K UNITS) and share (%) By End-use, 2017-2025
    4.5.2. Pinworm Infection Treatment Market Consumption and Growth Rate, 2017-2025
    4.5.3. Ascaris Infection Treatment Market Consumption and Growth Rate, 2017-2025
    4.5.4. Others Market Consumption and Growth Rate, 2017-2025

    CHAPTER 5. GLOBAL ALBENDAZOLE MARKET BY REGION, 2017-2025
    5.1. NORTH AMERICA
    5.1.1. U.S.
    5.1.2. Canada
    5.1.3. Mexico
    5.2. EUROPE
    5.2.1. U.K.
    5.2.2. France
    5.2.3. Germany
    5.2.4. Italy
    5.2.5. Spain
    5.2.6. Rest of Europe
    5.3. ASIA PACIFIC
    5.3.1. China
    5.3.2. Japan
    5.3.3. India
    5.3.4. Korea
    5.3.5. Rest of APAC
    5.4. SOUTH AMERICA
    5.4.1. Brazil
    5.4.2. Rest of South America
    5.5. REST OF THE WORLD
    5.5.1. Middle East
    5.5.2. Africa
    5.6. GLOBAL ALBENDAZOLE MARKET REVENUE BY REGION, 2017-2025
    5.6.1. Global albendazole Market Revenue (Million USD) and Share (%) By Region, 2017-2025
    5.6.2. North America Market Revenue and Growth Rate, 2017-2025
    5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
    5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
    5.6.5. South America Market Revenue and Growth Rate, 2017-2025
    5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025

    CHAPTER 6. GLOBAL ALBENDAZOLE MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
    6.1. GLOBAL ALBENDAZOLE MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
    6.1.1. Global albendazole Market Production (K UNITS) and Share (%) By Region, 2017-2025
    6.1.2. Global albendazole Market Consumption (K UNITS) and Share (%) By Region, 2017-2025
    6.1.3. North America Market Production and Consumption, 2017-2025
    6.1.4. Europe Market Production and Consumption, 2017-2025
    6.1.5. Asia Pacific Market Production and Consumption, 2017-2025
    6.1.6. South America Market Production and Consumption, 2017-2025
    6.1.7. Rest of the World Market Production and Consumption, 2017-2025

    CHAPTER 7. MARKET DETERMINANTS
    7.1. MARKET DRIVERS
    7.2. MARKET RESTRAINTS
    7.3. MARKET OPPORTUNITIES
    7.4. MARKET DETERMINANTS RADAR CHART

    CHAPTER 8. GLOBAL ALBENDAZOLE MARKET COMPETITION BY MANUFACTURERS
    8.1. GLOBAL ALBENDAZOLE PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
    8.1.1. Global albendazole Production (K UNITS) and Share (%) by Manufacturers (2017-2025)
    8.2. GLOBAL ALBENDAZOLE REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
    8.2.1. Global albendazole Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
    8.3. ALBENDAZOLE MARKET COMPETITIVE SITUATION AND TRENDS
    8.3.1. albendazole Market Share (%) of Top 3 Manufacturers
    8.3.2. albendazole Market Share (%) of Top 5 Manufacturers

    CHAPTER 9. GLOBAL ALBENDAZOLE MANUFACTURERS ANALYSIS
    9.1. GLAXOSMITHKLINE
    9.1.1. Business Overview
    9.1.2. Company Basic Information
    9.1.3. albendazole Product Details
    9.1.4. GlaxoSmithKline albendazole Production, Revenue and Gross Margin
    9.2. CHANGZHOU YABANG
    9.2.1. Business Overview
    9.2.2. Company Basic Information
    9.2.3. albendazole Product Details
    9.2.4. CHANGZHOU YABANG albendazole Production, Revenue and Gross Margin
    9.3. SUPHARMA CHEM
    9.3.1. Business Overview
    9.3.2. Company Basic Information
    9.3.3. albendazole Product Details
    9.3.4. Supharma Chem albendazole Production, Revenue and Gross Margin
    9.4. HUBEI KEYI
    9.4.1. Business Overview
    9.4.2. Company Basic Information
    9.4.3. albendazole Product Details
    9.4.4. HUBEI KEYI albendazole Production, Revenue and Gross Margin
    9.5. SEQUENT SCIENTIFI
    9.5.1. Business Overview
    9.5.2. Company Basic Information
    9.5.3. albendazole Product Details
    9.5.4. Sequent Scientifi albendazole Production, Revenue and Gross Margin
    9.6. LASA LABORATORY PVT LTD
    9.6.1. Business Overview
    9.6.2. Company Basic Information
    9.6.3. albendazole Product Details
    9.6.4. Lasa Laboratory Pvt Ltd albendazole Production, Revenue and Gross Margin
    9.7. K.A.MALLE PHARMACEUTICALS
    9.7.1. Business Overview
    9.7.2. Company Basic Information
    9.7.3. albendazole Product Details
    9.7.4. K.A.Malle Pharmaceuticals albendazole Production, Revenue and Gross Margin
    9.8. SALIUS PHARMA
    9.8.1. Business Overview
    9.8.2. Company Basic Information
    9.8.3. albendazole Product Details
    9.8.4. Salius Pharma albendazole Production, Revenue and Gross Margin
    9.9. LEO BIO-CARE PVT.
    9.9.1. Business Overview
    9.9.2. Company Basic Information
    9.9.3. albendazole Product Details
    9.9.4. Leo Bio-Care Pvt. albendazole Production, Revenue and Gross Margin
    9.10. FREDUN PHARMACEUTICALS LTD
    9.10.1. Business Overview
    9.10.2. Company Basic Information
    9.10.3. albendazole Product Details
    9.10.4. Fredun Pharmaceuticals Ltd albendazole Production, Revenue and Gross Margin

    CHAPTER 10. ALBENDAZOLE MARKET VALUE CHAIN ANALYSIS
    10.1. ALBENDAZOLE INDUSTRIAL CHAIN ANALYSIS
    10.2. ALBENDAZOLE KEY RAW MATERIALS ANALYSIS
    10.2.1. Key Raw Materials
    10.2.2. Price Trend of Key Raw Materials
    10.2.3. Key Suppliers of Raw Materials
    10.3. MARKETING CHANNEL
    10.3.1. Direct Marketing
    10.3.2. Indirect Marketing
    10.3.3. Distributors/Traders
    10.4. CONSUMER ANALYSIS
    10.4.1. Consumer 1
    10.4.2. Consumer 2
    10.4.3. Consumer 3
    10.4.4. Consumer 4

    keyboard_arrow_up
  • • CHANGZHOU YABANG
    • GlaxoSmithKline
    • Supharma Chem
    • HUBEI KEYI
    • Sequent Scientifi
    • Lasa Laboratory Pvt Ltd
    • K.A.Malle Pharmaceuticals
    • Leo Bio-Care Pvt.
    • Salius Pharma
    • Fredun Pharmaceuticals Ltd
    • Hubei Zhongjia-chem Pharmaceutical
    • Ashish Life Science Pvt. Ltd.
    • AdvacarePharma
    • MANAV DRUGS
    • Huazhong Pharmaceutical

    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Information does this report contain?

• What was the market size of the Albendazole Market in 2017 and the expected market size by 2025, along with the growth rate?
• An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
• Which are the largest revenue generating products, services or regions and their comparative growth rate?
• Which technology is in trend and how would it evolve during the forecast period (2017 – 2025)?
• Which are the leading companies in the Albendazole Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

CLIENTS